Optimal outcomes depend on addressing precipitating factors, close monitoring of biochemical parameters, and multidisciplinary specialist involvement to coordinate insulin therapy, manage metabolic derangements, and prevent recurrence of DKA or pancreatitis [15, 16]. The gene discussed is INS; the disease is pancreatitis.